Manitex International, Inc. is a provider of engineered specialty lifting and loading products. The company has market cap of $126.98 million. The Firm operates in three business divisions: the Lifting Equipment segment, the A.S.V., LLC segment and the Equipment Distribution segment. It currently has negative earnings. Through its Lifting Equipment segment, the Company designs, makes and distributes a diverse group of products that serve various functions and are used in a range of industries.
JP Morgan Cazenove currently has a GBX 240.00 target on the 1.11B GBP market cap company or 48.33% upside potential. In a note made public on Wednesday, 22 March, Vectura Group PLC (LON:VEC) stock had its “Overweight” Rating kept by stock analysts at JP Morgan Cazenove.
Analysts await Manitex International Inc (NASDAQ:MNTX) to report earnings on May, 4. They expect $-0.04 earnings per share, down 300.00% or $0.06 from last year’s $0.02 per share. After $0.02 actual earnings per share reported by Manitex International Inc for the previous quarter, Wall Street now forecasts -300.00% negative EPS growth.
The stock decreased 2.60% or $0.21 during the last trading session, reaching $7.88. About shares traded. Manitex International Inc (NASDAQ:MNTX) has risen 31.55% since August 15, 2016 and is uptrending. It has outperformed by 24.53% the S&P500.
Wealthtrust Axiom Llc holds 1.83% of its portfolio in Manitex International Inc for 736,266 shares. Rutabaga Capital Management Llc Ma owns 1.41 million shares or 1.66% of their US portfolio. Moreover, First Wilshire Securities Management Inc has 1.07% invested in the company for 544,184 shares. The Oregon-based Pacific Ridge Capital Partners Llc has invested 1.02% in the stock. Weber Alan W, a New York-based fund reported 216,531 shares.
About 1.05M shares traded. Vectura Group PLC (LON:VEC) has risen 15.93% since August 23, 2016 and is uptrending. It has outperformed by 8.91% the S&P500.
Among 10 analysts covering Vectura Group PLC (LON:VEC), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Vectura Group PLC has GBX 279 highest and GBX 160 lowest target. GBX 212.70’s average target is 31.54% above currents GBX 161.7 stock price. Vectura Group PLC had 85 analyst reports since July 28, 2015 according to SRatingsIntel. As per Tuesday, January 17, the company rating was maintained by JP Morgan. The company was maintained on Thursday, May 26 by Stifel Nicolaus. Peel Hunt maintained Vectura Group PLC (LON:VEC) rating on Thursday, February 16. Peel Hunt has “Buy” rating and GBX 200 target. The stock of Vectura Group PLC (LON:VEC) earned “Buy” rating by N+1 Singer on Wednesday, February 10. The firm has “Outperform” rating by RBC Capital Markets given on Tuesday, March 1. As per Tuesday, August 30, the company rating was maintained by Numis Securities. The stock of Vectura Group PLC (LON:VEC) has “Buy” rating given on Monday, September 5 by Numis Securities. The company was maintained on Tuesday, August 30 by Peel Hunt. Stifel Nicolaus maintained Vectura Group PLC (LON:VEC) on Tuesday, August 30 with “Buy” rating. The stock has “Buy” rating by FinnCap on Tuesday, July 28.
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The company has market cap of 1.11 billion GBP. The Company’s products include Ultibro Breezhaler and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA. It currently has negative earnings. The Company’s product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465.
Analysts await Vectrus Inc (NYSE:VEC) to report earnings on May, 9.
